Your browser doesn't support javascript.
loading
CRSP8 promotes thyroid cancer progression by antagonizing IKKα-induced cell differentiation.
Liao, Yina; Hua, Yijun; Li, Yizhuo; Zhang, Changlin; Yu, Wendan; Guo, Ping; Zou, Kun; Li, Wenyang; Sun, Yao; Wang, Ruozhu; Zuo, Yan; Sui, Silei; Tian, Chunfang; Hao, Jiaojiao; Chen, Manyu; Hu, Sheng; Chen, Miao; Long, Qian; Wang, Xiaonan; Zou, Lijuan; Xie, Fangyun; Guo, Wei; Deng, Wuguo.
Afiliación
  • Liao Y; Institute of Cancer Stem Cells & The First Affiliated Hospital, Dalian Medical University, Dalian, China.
  • Hua Y; Shanghai Center for Thyroid Disease, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, China.
  • Li Y; Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center of Cancer Medicine, Guangzhou, China.
  • Zhang C; Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center of Cancer Medicine, Guangzhou, China.
  • Yu W; The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, China.
  • Guo P; Institute of Cancer Stem Cells & The First Affiliated Hospital, Dalian Medical University, Dalian, China.
  • Zou K; Institute of Cancer Stem Cells & The First Affiliated Hospital, Dalian Medical University, Dalian, China.
  • Li W; Institute of Cancer Stem Cells & The First Affiliated Hospital, Dalian Medical University, Dalian, China.
  • Sun Y; Institute of Cancer Stem Cells & The First Affiliated Hospital, Dalian Medical University, Dalian, China.
  • Wang R; Institute of Cancer Stem Cells & The First Affiliated Hospital, Dalian Medical University, Dalian, China.
  • Zuo Y; Institute of Cancer Stem Cells & The First Affiliated Hospital, Dalian Medical University, Dalian, China.
  • Sui S; Institute of Cancer Stem Cells & The First Affiliated Hospital, Dalian Medical University, Dalian, China.
  • Tian C; Institute of Cancer Stem Cells & The First Affiliated Hospital, Dalian Medical University, Dalian, China.
  • Hao J; Institute of Cancer Stem Cells & The First Affiliated Hospital, Dalian Medical University, Dalian, China.
  • Chen M; Institute of Cancer Stem Cells & The First Affiliated Hospital, Dalian Medical University, Dalian, China.
  • Hu S; Institute of Cancer Stem Cells & The First Affiliated Hospital, Dalian Medical University, Dalian, China.
  • Chen M; Institute of Cancer Stem Cells & The First Affiliated Hospital, Dalian Medical University, Dalian, China.
  • Long Q; Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center of Cancer Medicine, Guangzhou, China.
  • Wang X; Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center of Cancer Medicine, Guangzhou, China.
  • Zou L; Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center of Cancer Medicine, Guangzhou, China.
  • Xie F; The Second Affiliated Hospital, Dalian Medical University, Dalian, China.
  • Guo W; Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center of Cancer Medicine, Guangzhou, China.
  • Deng W; Institute of Cancer Stem Cells & The First Affiliated Hospital, Dalian Medical University, Dalian, China. wei1015@dmu.edu.cn.
Cell Death Differ ; 28(4): 1347-1363, 2021 04.
Article en En | MEDLINE | ID: mdl-33162555
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Tiroides / Resistencia a Antineoplásicos / Quinasa I-kappa B / Complejo Mediador / Carcinoma Anaplásico de Tiroides Límite: Animals / Humans / Male Idioma: En Revista: Cell Death Differ Año: 2021 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Tiroides / Resistencia a Antineoplásicos / Quinasa I-kappa B / Complejo Mediador / Carcinoma Anaplásico de Tiroides Límite: Animals / Humans / Male Idioma: En Revista: Cell Death Differ Año: 2021 Tipo del documento: Article País de afiliación: China